These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7437864)

  • 1. Azoospermia after iodine-131 treatment for thyroid carcinoma.
    Handelsman DJ; Conway AJ; Donnelly PE; Turtle JR
    Br Med J; 1980 Dec; 281(6254):1527. PubMed ID: 7437864
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma.
    Ahmed SR; Shalet SM
    Postgrad Med J; 1985 Apr; 61(714):361-2. PubMed ID: 4022871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 4. Iodide mumps: a case report of complicated radioactive iodine causing sialadenitis.
    Lei L; Velasco O; Nobay F
    Am J Emerg Med; 2012 Mar; 30(3):512.e5-6. PubMed ID: 21354757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive iodine 1311 (RAI) treatment. The nearest to the "magic bullet" but should always be preceded by a risk assessment, especially in the pediatric patient.
    Lubin E
    Pediatr Endocrinol Rev; 2011 Sep; 9(1):415-6. PubMed ID: 22783638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
    Kalinyak JE; McDougall IR
    Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
    [No Abstract]   [Full Text] [Related]  

  • 7. Mallory-Weiss syndrome caused by iodine-131 therapy for metastatic thyroid carcinoma.
    Kinuya S; Hwang EH; Ikeda E; Yokoyama K; Michigishi T; Tonami N
    J Nucl Med; 1997 Nov; 38(11):1831. PubMed ID: 9374366
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer in iodine-131 exposed patients.
    Hall P; Holm LE
    J Endocrinol Invest; 1995 Feb; 18(2):147-9. PubMed ID: 7629384
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction.
    Cetinkaya A; Kersten RC
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):496. PubMed ID: 18030131
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid blocking policy--revisited.
    Solanki KK; Bomanji JB; Waddington WA; Ell PJ;
    Nucl Med Commun; 2004 Nov; 25(11):1071-6. PubMed ID: 15577583
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonadal damage from 131I therapy for thyroid cancer.
    Mazzaferri EL
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):313-4. PubMed ID: 12201822
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioactive iodine and testicular damage.
    Ahmed SR; Shalet SM
    N Engl J Med; 1984 Dec; 311(24):1576. PubMed ID: 6504085
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancytopenia after repeated radioiodine treatment on metastatic thyroid cancer to bone.
    Tanigawa K; Yamashita S; Nagataki S
    Chin Med J (Engl); 1995 Oct; 108(10):796-7. PubMed ID: 8565674
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
    Kim DW
    Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient release issue reopened.
    J Nucl Med; 2010 Dec; 51(12):13N. PubMed ID: 21098785
    [No Abstract]   [Full Text] [Related]  

  • 16. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
    Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
    J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
    Sgouros G
    J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
    [No Abstract]   [Full Text] [Related]  

  • 18. Professional groups respond.
    J Nucl Med; 2010 Dec; 51(12):13N. PubMed ID: 21098784
    [No Abstract]   [Full Text] [Related]  

  • 19. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
    Kennedy JS; Thomson JA
    J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.